- Investing Ideas
- Taiwanese Pharmaceuticals & Biotech Low Leverage High Rewards
Taiwanese Pharmaceuticals & Biotech Low Leverage High Rewards
Results
10
10 companies
Syngen BiotechLtd
Market Cap: NT$2.6b
Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally.
8279
NT$96.80
7D
0.5%
1Y
-31.1%
TSH Biopharm
Market Cap: NT$1.9b
Develops and markets pharmaceutical products in Taiwan.
8432
NT$50.20
7D
-2.0%
1Y
0.8%
TTY Biopharm
Market Cap: NT$18.3b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.
4105
NT$74.40
7D
0.7%
1Y
-2.0%
SYN-TECH Chem. & Pharm
Market Cap: NT$3.2b
Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.
1777
NT$71.70
7D
0.6%
1Y
-18.5%
Synmosa Biopharma
Market Cap: NT$15.1b
A specialty pharmaceutical company, engages in the manufacturing and sales of various pharmaceuticals and medical devices in Taiwan, China, the United States, Canada, Thailand, Malaysia, Singapore, and internationally.
4114
NT$30.10
7D
-1.5%
1Y
-3.3%
Chi Sheng Pharma & Biotech
Market Cap: NT$1.8b
Manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally.
4111
NT$30.05
7D
0%
1Y
5.0%
Standard Chemical & Pharmaceutical
Market Cap: NT$11.0b
Manufactures and sells pharmaceutical products in Taiwan and internationally.
1720
NT$61.90
7D
0.5%
1Y
7.3%
YungShin Global Holding
Market Cap: NT$14.9b
Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics.
3705
NT$56.40
7D
1.3%
1Y
-8.9%
Winston Medical Supply
Market Cap: NT$1.2b
Winston Medical Supply Co.,Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally.
6817
NT$63.70
7D
3.2%
1Y
-39.3%
Sinphar PharmaceuticalLtd
Market Cap: NT$5.9b
Engages in the production, processing, selling, and trading of various medicines, chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.
1734
NT$31.30
7D
2.6%
1Y
2.1%